非オピオイド鎮痛治療の世界市場

非オピオイド鎮痛治療の世界市場は2030年までに660億米ドルに達する見込み

2024年に440億米ドルと推定された非オピオイド鎮痛治療の世界市場は、2030年には660億米ドルに達し、分析期間2024-2030年のCAGRは7.0%で成長すると予測されます。本レポートで分析したセグメントの1つである非ステロイド性抗炎症薬は、CAGR 8.0%を記録し、分析期間終了時には296億米ドルに達すると予測されます。アセトアミノフェン医薬品セグメントの成長率は、分析期間中CAGR 7.6%と推定されます。

米国市場は推定120億米ドル、中国はCAGR 11.1％で成長予測

米国の非オピオイド鎮痛治療市場は2024年に120億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに139億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.4%と6.8%と予測されています。欧州では、ドイツがCAGR 4.6%で成長すると予測されています。

世界の非オピオイド鎮痛治療市場- 主要動向と促進要因まとめ

なぜ世界のヘルスケア産業はオピオイドベースの疼痛管理から脱却しつつあるのか？

非オピオイド鎮痛治療への世界の移行は、現代の疼痛管理における最も重要なシフトの一つであり、オピオイド中毒や依存、関連する医療負担に対する懸念の高まりがそのきっかけとなっています。特に北米では、数十年にわたるオピオイドの誤用の増加に対応するため、臨床医、規制当局、製薬企業イノベーターは、急性および慢性の痛みの両方に対して、より安全で依存性のない代替薬を優先して使用しています。オピオイドの過剰処方がもたらす壊滅的な結果は、規制当局の取り締まり、医療ガイドラインの改訂、痛みの治療方法に関する文化的な大きな見直しにつながっています。その結果、非オピオイド治療（非ステロイド性抗炎症薬、抗うつ薬、抗けいれん薬など）、標的生物学的製剤、神経遮断薬、TENS（経皮的電気神経刺激）や脊髄刺激装置のような器具を用いた治療など、幅広い治療が行われるようになりました。これらの治療の多くは、気分や認知機能を変化させたり、依存のリスクを冒すことなく疼痛を効果的に管理できるため、関節炎の高齢患者からスポーツ外傷や手術から回復した若年層まで、患者の属性を問わず魅力的です。緩和ケアや術後ケアでは、非オピオイド療法を理学療法、心理的サポート、生活習慣の調整と統合する、マルチモーダルなアプローチが主流になりつつあります。オピオイドのリスクに対する認識が高まるにつれ、たとえ医学的管理下で服用されていたとしても、患者自身がオピオイド以外の代替薬を探し求め、要求するようになってきており、ヘルスケアシステムにはさらなる進化へのプレッシャーがかかっています。この世界のパラダイムシフトにより、疼痛治療は単なる臨床的課題としてではなく、学際的で個別化された、公衆衛生主導の優先課題として再定義されつつあります。

薬理学と医療機器の革新は、疼痛治療のツールボックスをどのように拡張しているのか？

薬理学と医療技術における最近の技術革新は、非オピオイド鎮痛治療の範囲と有効性を大幅に拡大し、これまで麻薬に依存していた何百万人もの患者に希望をもたらしています。製薬業界では、脳の報酬系に影響を与えることなく、特定の痛覚経路を標的とする新規化合物の開発が進んでいます。例えば、選択的神経成長因子（NGF）阻害剤は変形性関節症などの慢性疾患に有望であり、COX-2阻害剤や次世代非ステロイド性抗炎症薬は、胃腸のリスクを軽減しながら鎮痛効果を向上させています。経口薬にとどまらず、局所ゲル、経皮パッチ、注射可能な生物製剤などの局所デリバリーシステムは、全身への曝露を最小限に抑えながら、部位特異的な緩和を提供します。医療機器の面では、TENSユニットや神経調節インプラントのような神経信号を調節するウェアラブル技術が、神経障害、線維筋痛症、術後疼痛などの症状に対する効果的なソリューションとして台頭してきています。このような非侵襲的あるいは低侵襲的な装置は、患者が薬理学的介入なしに長期的な症状管理を必要とする外来患者において特に魅力的です。また、気晴らしや認知的リフレーミング技術を用いたバーチャルリアリティ（VR）ベースの治療法も、臨床試験において疼痛軽減のために検討されています。一方、AIを搭載したプラットフォームは、遺伝学、行動、ライフスタイルのデータを分析することで、臨床医が個々の患者に合わせて痛みの治療レジメンを調整するのに役立っています。バイオテクノロジー、デジタル治療学、精密医療の融合は、非オピオイド鎮痛治療を実現可能なものにしているだけでなく、多くの場合、望ましいものにしています。これらの技術革新は、疼痛に対する理解や対処の仕方を変えつつあり、その焦点は抑制から調節や長期管理へと移っています。

公衆衛生政策と支払者戦略は非オピオイド選択肢へのシフトを加速させているか？

オピオイドを使用しない疼痛治療の普及は、オピオイド依存の抑制を目的とした公衆衛生政策、保険支払者戦略、医療機関の処方ガイドラインによって大きく後押しされています。国家的なオピオイド危機を受け、特に米国、カナダ、オーストラリアをはじめとする世界各国の政府は、厳格な処方監視プログラムを実施し、非オピオイド系疼痛治療薬の開発と普及に助成金を提供しています。FDAのような規制機関は、代替薬の緊急の必要性を認識し、いくつかの非オピオイド系鎮痛薬や器具の承認を急ピッチで進めています。保険会社は、理学療法、鍼治療、カイロプラクティック、認知行動療法（CBT）などの非薬物療法を含む、非オピオイド療法のより広範な適用を支援するために、償還の枠組みを改定しています。また、一部のヘルスケアシステムでは、オピオイドを温存するプロトコルを採用する病院やクリニックに財政的インセンティブを導入しています。さらに、整形外科、歯科、麻酔科、緩和ケアの各専門家団体は、特定の疾患や術後のシナリオに対する第一選択治療として、オピオイドを使用しない選択肢を推奨する最新のガイドラインを発表しています。オピオイドの長期的な危険性を強調し、より安全でエビデンスに基づいた選択肢を提示する教育キャンペーンが、医師と一般市民の両方を対象に同時に行われています。病院や大学医療センターでは、複数の非オピオイド療法を統合し、総合的に疼痛を治療する専用の疼痛管理プログラムを開始しています。このような政策レベルの取り組みは、医療行為基準を再構築するだけでなく、非薬物・非オピオイドアプローチに対する偏見を減らし、持続可能で患者中心の疼痛管理の新しい文化を育んでいます。

世界の非オピオイド鎮痛治療市場の成長を促進する要因とは？

非オピオイド鎮痛治療市場の成長は、テクノロジー、ヘルスケア提供、患者行動、疫学的動向など、いくつかの連動した要因によってもたらされます。技術的には、生物学的製剤、神経遮断薬、デジタル治療薬など、より安全で標的を絞った治療法の開発により、非オピオイド疼痛管理の臨床的可能性がより広範な病態で拡大しています。人口の高齢化、座りっぱなしのライフスタイル、外科手術、関節炎、がん、糖尿病などの疾患に起因する慢性疼痛の有病率の増加は、効果的で忍容性のある疼痛解決策に対する世界の需要を持続的に生み出しています。臨床面では、集学的治療チームと個別化医療アプローチの統合が、多様で非中毒性の治療法の必要性を強めています。システムの観点からは、ヘルスケアプロバイダーは法的責任を軽減し、患者の満足度を向上させ、施設の業績評価指標を満たすために、オピオイドを温存する戦略を優先しています。保険適用は徐々に非オピオイド療法を含むようになってきており、患者への幅広いアクセスと自己負担の軽減を可能にしています。消費者側では、健康リテラシーの向上とオピオイド関連薬害に対する社会的意識の高まりにより、患者が積極的に代替治療を求め、より安全な治療経路を支持するようになっています。さらに、COVID-19の大流行は、オピオイド依存システムの脆弱性を露呈し、自宅で管理できる分散型、デバイスベース、または非薬物的介入の重要性をさらに立証しました。製薬会社や医療技術企業は、強固な研究開発パイプラインと、世界の市場浸透の拡大を目指した戦略的パートナーシップで対応しています。このような技術的、臨床的、経済的、文化的な変化が相まって、非オピオイド鎮痛治療市場には持続的かつ加速的な成長の波が押し寄せています。

セグメント

薬剤クラス（非ステロイド性抗炎症薬、アセトアミノフェン薬、局所麻酔薬、その他薬剤クラス別）;痛み（慢性疼痛、術後疼痛、がん性疼痛、その他疼痛）;投与経路（経口投与経路、局所投与経路、注射投与経路、その他投与経路）;流通チャネル（小売薬局、病院薬局、オンライン薬局）

調査対象企業の例

• Almatica Pharma LLC
• Amgen Inc.
• Cipla Inc.
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly and Company
• Fresenius Kabi AG
• GlaxoSmithKline plc（GSK）
• Haleon Group
• Heron Therapeutics
• Hyloris Pharmaceuticals
• Johnson & Johnson Consumer Inc.
• LNK International, Inc.
• Novartis AG
• Pacira Pharmaceuticals, Inc.
• Perrigo Company plc
• Pfizer Inc.
• Pierrel S.p.A.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Vertex Pharmaceuticals Incorporated

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMをクエリする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Non-opioid Pain Treatment Market to Reach US$66.0 Billion by 2030

The global market for Non-opioid Pain Treatment estimated at US$44.0 Billion in the year 2024, is expected to reach US$66.0 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Non-Steroidal Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$29.6 Billion by the end of the analysis period. Growth in the Acetaminophen Drugs segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.0 Billion While China is Forecast to Grow at 11.1% CAGR

The Non-opioid Pain Treatment market in the U.S. is estimated at US$12.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$13.9 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Non-Opioid Pain Treatment Market - Key Trends & Drivers Summarized

Why Is the Global Healthcare Industry Moving Away from Opioid-Based Pain Management?

The global transition toward non-opioid pain treatment represents one of the most significant shifts in modern pain management, catalyzed by growing concerns over opioid addiction, dependence, and associated healthcare burdens. In response to decades of rising opioid misuse-particularly in North America-clinicians, regulators, and pharmaceutical innovators are prioritizing safer, non-addictive alternatives for both acute and chronic pain. The devastating consequences of opioid overprescription have led to regulatory crackdowns, medical guideline revisions, and a major cultural rethinking of how pain should be treated. This has created a fertile environment for non-opioid treatments, which include a wide range of pharmaceuticals (such as NSAIDs, antidepressants, and anticonvulsants), targeted biologics, nerve-blocking agents, and device-based therapies like TENS (Transcutaneous Electrical Nerve Stimulation) and spinal cord stimulators. Many of these treatments can effectively manage pain without altering mood, cognitive function, or risking dependence, making them attractive across patient demographics-from elderly patients with arthritis to younger populations recovering from sports injuries or surgeries. In palliative and post-operative care, multimodal approaches are now becoming the norm, wherein non-opioid solutions are integrated with physical therapy, psychological support, and lifestyle adjustments. As awareness grows around the risks of opioids-even when taken under medical supervision-patients themselves are increasingly seeking out and requesting non-opioid alternatives, placing additional pressure on healthcare systems to evolve. This global paradigm shift is redefining pain treatment not just as a clinical challenge but as a multidisciplinary, personalized, and public health-driven priority.

How Are Innovations in Pharmacology and Medical Devices Expanding the Pain Treatment Toolbox?

Recent innovations in pharmacology and medical technology are vastly expanding the range and efficacy of non-opioid pain treatments, offering hope for millions of patients previously dependent on narcotics for relief. On the pharmaceutical front, companies are developing novel compounds that target specific pain pathways without affecting the brain’s reward system-thereby reducing the potential for misuse. For instance, selective nerve growth factor (NGF) inhibitors are showing promise for chronic conditions like osteoarthritis, while COX-2 inhibitors and next-generation NSAIDs are delivering improved pain relief with reduced gastrointestinal risks. Beyond oral drugs, localized delivery systems such as topical gels, transdermal patches, and injectable biologics offer site-specific relief with minimal systemic exposure. On the medical device side, wearable technologies that modulate nerve signals-like TENS units and neuromodulation implants-are emerging as effective solutions for conditions such as neuropathy, fibromyalgia, and post-surgical pain. These non-invasive or minimally invasive devices are particularly appealing in outpatient settings where patients require long-term symptom management without pharmacologic intervention. Virtual reality (VR)-based therapies, which use distraction and cognitive reframing techniques, are also being explored for pain reduction in clinical trials. Meanwhile, AI-powered platforms are helping clinicians tailor pain treatment regimens to individual patients by analyzing genetics, behavior, and lifestyle data. The convergence of biotechnology, digital therapeutics, and precision medicine is making non-opioid pain treatment not only viable but in many cases, preferable. These innovations are transforming how pain is understood and addressed-shifting the focus from suppression to modulation and long-term management.

Are Public Health Policies and Payer Strategies Accelerating the Shift to Non-Opioid Options?

The rising adoption of non-opioid pain treatments is being significantly driven by public health policies, insurance payer strategies, and institutional prescribing guidelines aimed at curbing opioid dependency. In the wake of national opioid crises, governments across the globe-especially in the U.S., Canada, and Australia-are implementing stringent prescription monitoring programs and providing grants for the development and dissemination of non-opioid pain solutions. Regulatory agencies like the FDA have fast-tracked approval for several non-opioid pain relief drugs and devices, recognizing the urgent need for alternatives. Insurance companies are revising reimbursement frameworks to support broader coverage of non-opioid therapies, including non-pharmacological interventions such as physical therapy, acupuncture, chiropractic care, and cognitive behavioral therapy (CBT). Some healthcare systems are also introducing financial incentives for hospitals and clinics that adopt opioid-sparing protocols. Moreover, professional associations in orthopedics, dentistry, anesthesiology, and palliative care have issued updated guidelines recommending non-opioid options as first-line treatments for specific conditions or post-operative scenarios. Educational campaigns are simultaneously targeting both physicians and the public, emphasizing the long-term dangers of opioids and presenting safer, evidence-based alternatives. Hospitals and academic medical centers are launching dedicated pain management programs that integrate multiple non-opioid modalities to treat pain holistically. These policy-level efforts are not only reshaping medical practice standards but are also reducing stigma around non-drug and non-opioid approaches, fostering a new culture of sustainable, patient-centered pain management.

What Factors Are Driving the Growth of the Non-Opioid Pain Treatment Market Globally?

The growth in the non-opioid pain treatment market is driven by several interlinked factors spanning technology, healthcare delivery, patient behavior, and epidemiological trends. Technologically, the development of safer, more targeted therapies-including biologics, nerve blockers, and digital therapeutics-is expanding the clinical viability of non-opioid pain management across a wider array of conditions. The increasing prevalence of chronic pain-stemming from aging populations, sedentary lifestyles, surgical procedures, and conditions like arthritis, cancer, and diabetes-is creating sustained global demand for effective and tolerable pain solutions. Clinically, the integration of multidisciplinary care teams and personalized medicine approaches is reinforcing the need for diverse, non-addictive treatment modalities. From a systems perspective, healthcare providers are prioritizing opioid-sparing strategies to reduce legal liabilities, improve patient satisfaction, and meet institutional performance metrics. Insurance coverage is gradually becoming more inclusive of non-opioid therapies, enabling broader patient access and reducing out-of-pocket costs. On the consumer side, growing health literacy and social awareness around opioid-related harm are pushing patients to actively seek alternative treatments and advocate for safer care pathways. Additionally, the COVID-19 pandemic exposed the vulnerability of opioid-dependent systems, further validating the importance of decentralized, device-based, or non-pharmacologic interventions that can be managed at home. Pharmaceutical companies and medtech firms are responding with robust R&D pipelines and strategic partnerships aimed at expanding market penetration globally. Together, these technological, clinical, economic, and cultural shifts are driving a durable and accelerating wave of growth in the non-opioid pain treatment market.

SCOPE OF STUDY:

The report analyzes the Non-opioid Pain Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drug Class (Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs, Other Drug Classes); Pain (Chronic Pain, Post-operative Pain, Cancer Pain, Other Pains); Route of Administration (Oral Route of Administration, Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Almatica Pharma LLC
• Amgen Inc.
• Cipla Inc.
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly and Company
• Fresenius Kabi AG
• GlaxoSmithKline plc (GSK)
• Haleon Group
• Heron Therapeutics
• Hyloris Pharmaceuticals
• Johnson & Johnson Consumer Inc.
• LNK International, Inc.
• Novartis AG
• Pacira Pharmaceuticals, Inc.
• Perrigo Company plc
• Pfizer Inc.
• Pierrel S.p.A.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Vertex Pharmaceuticals Incorporated

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Non-opioid Pain Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Opioid Addiction Crisis Throws the Spotlight on Safer, Non-Addictive Pain Management Alternatives
  • Heightened Regulatory Scrutiny and Prescribing Restrictions Strengthen the Business Case for Non-Opioid Therapies
  • Shift Toward Multimodal Pain Management Approaches Propels Growth in Non-Opioid Treatment Options
  • Surging Demand for Chronic Pain Relief Among Aging Populations Expands the Addressable Market Opportunity
  • Innovations in Targeted Drug Delivery and Non-Systemic Therapies Drive Adoption Across Diverse Indications
  • Advancements in Neuromodulation and Non-Invasive Devices Accelerate Demand for Non-Pharmacologic Interventions
  • Rise in Post-Surgical and Musculoskeletal Conditions Spurs Uptake of Non-Opioid Pain Solutions in Acute Care Settings
  • Integration with Digital Therapeutics and AI-Based Treatment Planning Enhances Patient Outcomes and Market Viability
  • Growing Preference for Personalized and Precision Medicine Supports Development of Condition-Specific Non-Opioid Regimens
  • Workplace Wellness Programs and Employer Health Initiatives Generate Demand for Safer Pain Relief Options
  • Expanding Use in Pediatrics and Geriatrics Drives the Need for Non-Opioid Treatments with Favorable Safety Profiles
  • Broader Consumer Awareness of Opioid Risks Fuels Patient-Led Demand for Safer, Sustainable Pain Treatments
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Non-opioid Pain Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Non-opioid Pain Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Acetaminophen Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Acetaminophen Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Acetaminophen Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Local Anesthetics Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Local Anesthetics Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Local Anesthetics Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Topical Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Topical Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Topical Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Injectable Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Injectable Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Injectable Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other Route of Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Oral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Oral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Oral Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Post-operative Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Post-operative Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Post-operative Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Cancer Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Other Pains by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Other Pains by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Other Pains by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Canada 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• JAPAN
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Japan 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• CHINA
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 86: China Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: China 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• EUROPE
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Non-opioid Pain Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• FRANCE
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 113: France Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: France 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• GERMANY
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Germany 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Italy 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 149: UK Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: UK 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Spain 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Russia 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Australia 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• INDIA
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 224: India Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: India 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: South Korea 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Non-opioid Pain Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Argentina 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Brazil 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Mexico 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Non-opioid Pain Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Iran 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Israel 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: UAE 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
• AFRICA
  • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Africa 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030

IV. COMPETITION